Exploring the scientific evidence behind glucocorticoid tapering strategies for Polymyalgia Rheumatica management
Discover how fibrinogen is emerging as a more specific biomarker than ESR or CRP for monitoring treatment response in Polymyalgia Rheumatica patients.